The US healthcare landscape is on the cusp of a major transformation, driven by groundbreaking biotech innovations. This article delves into three pivotal technologies – personalized medicine, CRISPR gene editing, and AI-powered diagnostics – that are set to redefine patient care, treatment efficacy, and disease prevention by 2027.

Discover the profound impact of gene editing by 2027 on U.S. citizens. This article delves into CRISPR technology, its practical applications, ethical considerations, and the regulatory landscape shaping its future.